Rare diseases
Investigational molecules
Locations
Back to Portugal684 clinical trials in Braga, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis
PortugalStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
PortugalStudy on the Effectiveness and Safety of Crovalimab vs. Eculizumab for Adults and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated with Complement Inhibitors
PortugalStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
PortugalStudy Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments
PortugalStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
PortugalStudy of inavolisib, palbociclib and fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
PortugalStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
PortugalStudy on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod
PortugalStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
PortugalStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
PortugalStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for multiple sclerosis, including chronic neuropathic pain management and new therapeutic approaches. Research also encompasses frontotemporal dementia and various types of migraines.
Studies focus on both symptom management and disease modification approaches.
Comprehensive research into various skin conditions, including plaque psoriasis, atopic dermatitis, and hidradenitis suppurativa. Clinical trials are evaluating new biological treatments and long-term management strategies.
Focus on developing targeted therapies for chronic skin conditions.
Investigation of novel treatments for autoimmune conditions, including studies on lupus nephritis and immune thrombocytopenia. Research aims to develop more effective therapeutic approaches.
Emphasis on innovative immunological interventions and targeted therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
